Per Djupesland

Biography

Per G. Djupesland, MD, PhD, is the inventor of Optinose’s patented, bi-directional nasal drug delivery technology and is a Co-Founder of the Company. Dr. Djupesland is a lead inventor on all 39 Optinose patent families/patent applications and serves as Chief Scientific Officer of OptiNose AS, with primary responsibility for device discovery and early development efforts. These early development efforts include identifying new product opportunities that use bi-directional technology, advancing the design of devices using the bi-directional technology to treat a variety of medical conditions and conducting Phase I and IIa trials with new “nose-to-brain” applications for the technology. Dr. Djupesland is an Otolaryngologist (ENT) with a specialization in rhinology and more than 25 years of clinical experience. Among other positions prior to Optinose, he served as a Clinical Research Fellow at The Hospital for Sick Children and Toronto General in Toronto, Canada, primarily studying the role of nitric oxide in the upper airways. Dr. Djupesland has authored more than 50 peer-reviewed articles in international medical journals and has lectured at numerous international scientific conferences. Dr. Djupesland earned medical and doctorate degrees in the fields of nasal physiology and aerodynamics from the University of Oslo.

Research Interest

Pharmaceutical Sciences